Celsion Now Covered by Analysts at HC Wainwright (CLSN)
Analysts at HC Wainwright initiated coverage on shares of Celsion (NASDAQ:CLSN) in a research report issued to clients and investors on Friday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $8.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 97.53% from the company’s current price.
Celsion (NASDAQ:CLSN) traded up 13.65% on Friday, hitting $4.603. 1,045,480 shares of the company’s stock traded hands. Celsion has a 52 week low of $3.3784 and a 52 week high of $42.5225. The stock has a 50-day moving average of $3.85 and a 200-day moving average of $4.8. The company’s market cap is $62.6 million.
Celsion (NASDAQ:CLSN) last released its earnings data on Tuesday, November 12th. The company reported ($0.30) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.23) by $0.08. The company had revenue of $0.13 million for the quarter. Analysts expect that Celsion will post $-0.59 EPS for the current fiscal year.
Celsion Corporation (NASDAQ:CLSN) is an oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.